ZNF385B, previously unrecognized as a potential ovarian tumour marker, and VEGFA correlated with overall and progression-free survival, respectively, whereas TPX2 and FOXM1 with optimal CA125 normalization. Here, FOXM1 is linked to ovarian neoplasm.